Last reviewed · How we verify
NCT06151002: PD Frontline
PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's
trial in Parkinson Disease in 4,800 participants. Currently enrolling.
14 February 2025
Quick facts
| Lead sponsor | University College London Hospitals |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 4,800 |
| Start date | 15 February 2020 |
| Primary completion | 14 February 2025 |
| Estimated completion | 20 August 2040 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University College London Hospitals
Who can join
Adults 18 to 90, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
PD Frontline (part of RAPSODI GD) is an online study observational study with the goal of bringing People with Parkinson's to the frontline of research by getting them trial ready. To do this, participants are offered genetic sequencing for the GBA and LRRK2 gene with an at-home saliva collection kit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06151002
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other University College London Hospitals trials
Trials by the same sponsor.
- NCT07206394 — Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome. · NA · recruiting
- NCT05725174 — Volatile Non-Invasive Biomarkers of Epileptic Seizures · recruiting
- NCT05362448 — Neurophysiologic Assessment of ET Patients Treated by Vim DBS · NA · unknown
- NCT05717465 — Communicating Risks: Consent for Lumbar Puncture · NA · completed
- NCT05460156 — The Bridges Self-management Programme for People With Neuromuscular Diseases · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06151002 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College London Hospitals
- Last refreshed: 30 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06151002.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing